Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
about
The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian ratsRotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome.Transdermal patches for the treatment of neurologic conditions in elderly patients: a review.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.
P2860
Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Rotigotine: transdermal dopami ...... se and restless legs syndrome.
@ast
Rotigotine: transdermal dopami ...... se and restless legs syndrome.
@en
type
label
Rotigotine: transdermal dopami ...... se and restless legs syndrome.
@ast
Rotigotine: transdermal dopami ...... se and restless legs syndrome.
@en
prefLabel
Rotigotine: transdermal dopami ...... se and restless legs syndrome.
@ast
Rotigotine: transdermal dopami ...... se and restless legs syndrome.
@en
P2860
P356
P1476
Rotigotine: transdermal dopami ...... se and restless legs syndrome.
@en
P2093
Michele Y Splinter
P2860
P304
P356
10.1345/APH.1H113
P407
P577
2007-01-09T00:00:00Z